ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System

March 5, 1999

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009

Kentucky Okays Cancer Commission, $1 Million Budget

April 21, 1978

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

May 29, 1998